NIH-funded research R21 grant

Testing gene therapies to help nerves heal after spinal cord injuries

Official title: Rapid In Vivo Screening of Combination Gene Therapies for Axonal Regeneration after Spinal Cord Injury

Funded at University of California, San Diego · NIH-10988849 · Data updated 2026-11-12

This study is exploring how mixing different gene therapies can help nerve cells heal after spinal cord injuries, with the hope of finding better ways to support recovery for people facing this challenge.

More Spinal Cord Injury research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego
NIH-funded
Lab location1 site (La Jolla, United States)
Project startSeptember 15, 2024
Project endAugust 31, 2026
Funding year2024
Award (this year)$437,250
NIH project number1R21NS135479-01A1
Project IDNIH-10988849 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults aged 21 and older who have experienced spinal cord injuries.

Less likely to help

Patients with spinal cord injuries who are under 21 years old or those with conditions unrelated to nerve regeneration may not benefit from this research.

What this research studies

This research investigates how different combinations of gene therapies can promote the regeneration of nerve cells after spinal cord injuries. Using advanced techniques like CRISPR and next-generation sequencing, the study will screen multiple genetic targets in a mouse model to identify the most effective combinations for enhancing nerve regeneration. By comparing these combinations in a pooled manner, the researchers aim to find new strategies that could lead to better recovery outcomes for patients with spinal cord injuries.

Why it matters

Potential benefit: If successful, this research could lead to innovative treatments that significantly improve recovery and quality of life for individuals with spinal cord injuries.

How similar studies have gone: Previous research has shown promise in using gene therapies for nerve regeneration, but this approach of pooled in vivo screening is novel and has not been extensively tested.

Where this research is happening

  • University of California, San Diego
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Lu, Pengzhe — University of California, San Diego
  • Study coordinator: Lu, Pengzhe

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.